Sitero Revenue and Competitors
Employee Data
- Sitero has 212 Employees.
- Sitero grew their employee count by 136% last year.
Sitero's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Technology Officer & President APAC | Reveal Email/Phone |
3 | VP Information Technology | Reveal Email/Phone |
4 | VP Products | Reveal Email/Phone |
5 | Biosafety Officer | Reveal Email/Phone |
6 | VP Business Development | Reveal Email/Phone |
7 | VP, IBC & Biosafety Services | Reveal Email/Phone |
8 | VP, Finance & Accounting | Reveal Email/Phone |
9 | Manager- GVP/GCP Quality & Audits | Reveal Email/Phone |
10 | Biosafety Officer | Reveal Email/Phone |
Sitero Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 212 | 136% | N/A | N/A |
#2 | N/A | 25 | 67% | N/A | N/A |
#3 | $7.5M | 113 | -4% | N/A | N/A |
#4 | N/A | 107 | 49% | N/A | N/A |
#5 | N/A | 46 | 44% | N/A | N/A |
#6 | N/A | 2 | -33% | N/A | N/A |
#7 | N/A | 38 | 58% | N/A | N/A |
#8 | N/A | 16 | 7% | N/A | N/A |
#9 | $7.5M | 66 | 18% | N/A | N/A |
What Is Sitero?
Sitero is a next-generation, site-focused clinical research organization (CRO) for life sciences and institutional research organizations that helps get treatments to market safer and faster through tech-forward services that streamline research. Accelerate your clinical trial, drive compliance and safety, and unlock innovation with access to powerful technology and world-class services. Sitero combines the expertise of a tenured team with a nimble, innovative approach to clinical research. Sitero has offices in the U.S., U.K., and India.
keywords:N/AN/A
Total Funding
212
Number of Employees
N/A
Revenue (est)
136%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 216 | 11% | N/A |
#2 | $70.2M | 220 | 22% | N/A |
#3 | $78.2M | 220 | 9% | N/A |
#4 | $24.3M | 221 | 5% | N/A |
#5 | $55.2M | 228 | 43% | N/A |